Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Ref Type | |||||||||||||
PMID | |||||||||||||
Authors | P Nghiem, S Bhatia, E J. Lipson, WH Sharfman, RR Kudchadkar, PA Friedlander, AS Brohl, A Daud, HM. Kluger, SA. Reddy, MA Burgess, BA Hanks, T Olencki, BC. Boulmay, LM Lundgren, N Ramchurren, BH Moreno, E Sharon, MA. Cheever, SL Topalian | ||||||||||||
Title | Durable tumor regression and overall survival (OS) in patients with advanced Merkel cell carcinoma (aMCC) receiving pembrolizumab as first-line therapy. | ||||||||||||
|
|||||||||||||
URL | http://ascopubs.org/doi/abs/10.1200/JCO.2018.36.15_suppl.9506 | ||||||||||||
Abstract Text | Journal of Clinical Oncology 36, no. 15_suppl (May 2018) 9506-9506. |
Molecular Profile | Treatment Approach |
---|
Gene Name | Source | Synonyms | Protein Domains | Gene Description | Gene Role |
---|
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|
Gene | Variant | Impact | Protein Effect | Variant Description | Associated with drug Resistance |
---|
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|